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Abstract
Background: Little research has directly compared the effectiveness of implementation strategies in any setting,
and we know of no prior trials directly comparing how effectively different combinations of strategies support
implementation in community health centers. This paper outlines the protocol of the Study of Practices Enabling
Implementation and Adaptation in the Safety Net (SPREAD-NET), a trial designed to compare the effectiveness of
several common strategies for supporting implementation of an intervention and explore contextual factors that
impact the strategies’ effectiveness in the community health center setting.
Methods/design: This cluster-randomized trial compares how three increasingly hands-on implementation
strategies support adoption of an evidence-based diabetes quality improvement intervention in 29 community
health centers, managed by 12 healthcare organizations. The strategies are as follows: (arm 1) a toolkit, presented in
paper and electronic form, which includes a training webinar; (arm 2) toolkit plus in-person training with a focus on
practice change and change management strategies; and (arm 3) toolkit, in-person training, plus practice facilitation
with on-site visits. We use a mixed methods approach to data collection and analysis: (i) baseline surveys on study
clinic characteristics, to explore how these characteristics impact the clinics’ ability to implement the tools and the
effectiveness of each implementation strategy; (ii) quantitative data on change in rates of guideline-concordant
prescribing; and (iii) qualitative data on the “how” and “why” underlying the quantitative results. The outcomes of
interest are clinic-level results, categorized using the Reach, Effectiveness, Adoption, Implementation, Maintenance
(RE-AIM) framework, within an interrupted time-series design with segmented regression models. This pragmatic
trial will compare how well each implementation strategy works in “real-world” practices.
Discussion: Having a better understanding of how different strategies support implementation efforts could
positively impact the field of implementation science, by comparing practical, generalizable methods for
implementing clinical innovations in community health centers. Bridging this gap in the literature is a critical step
towards the national long-term goal of effectively disseminating and implementing effective interventions into
community health centers.
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Background
The adoption and implementation of evidence-based
care guidelines and quality improvement (QI) practices
into everyday practice is limited; hence, scientific ad-
vances rarely reach their population potential in a
timely manner [1–12]. One underlying reason is that
most prior research focused on developing and evaluat-
ing interventions but not on the distinct methods used
to support such interventions’ uptake into practice
[13–15]. As a result, there is incomplete knowledge
about what strategies best support implementing
proven innovations [2–9]. Broadly defined, “implemen-
tation strategies” may include the following: policies to
incentivize intended users to adopt targeted innova-
tions, providing treatment guidelines, decision support,
training, consultation, facilitation, and/or feedback data;
and using QI approaches such as workflow redesign,
Plan-Do-Study-Act cycles, and other change manage-
ment practices [16–18].
The Study of Practices Enabling Implementation and
Adaptation in the Safety Net (SPREAD-NET) builds on
existing knowledge on the efficacy of different strategies
for implementing interventions that seek to improve
clinical outcomes by changing clinician behaviors. Aca-
demic detailing (expert consultation)/educational out-
reach are generally effective at changing provider
behaviors, other process measures, and clinical out-
comes [19–23]. Interactive small group trainings have a
modest positive effect on provider performance [24–26].
In-person training and “train-the-trainer” approaches are
supported by substantial evidence [8]. Toolkits can sup-
port implementation of guideline-based care [27], but
“passive” implementation—i.e., simply providing a toolk-
it—shows mixed effectiveness [19]. “Auditing” and giving
feedback data can change provider behaviors and other
process measures but have mixed effects on clinical out-
comes [28–38]. Practice facilitation (when skilled individ-
uals help clinic staff implement interventions) [39, 40] can
support enhanced care quality—for example, primary care
practices are 2.76 (95 % CI, 2.18–3.43) times more likely
to adopt guidelines if practice facilitation is used [39] but
has mixed effects on clinical outcomes [39–41].
As the most prior research studied one implementa-
tion strategy at a time, little is known about the benefits
of multiple, concurrent implementation strategies (e.g.,
training plus technical assistance). Further, little research
has directly compared the effectiveness of different im-
plementation strategies in any setting [16, 17, 42, 43],
much less in Community Health Centers (CHCs) [2], so
it is unknown which individual or combined strategie-
s—even those that work in more controlled research set-
tings or private/academic settings—will work in CHCs.
This is problematic, because CHCs serve millions of so-
cioeconomically vulnerable patients in the USA [43–47].
In addition, little research has been conducted on the in-
fluence of context on the effectiveness of various imple-
mentation strategies [31]—i.e., which strategies are
optimal in which settings and why [48, 49]. We believe
that the “SPREAD-NET” trial is the first to compare the
effectiveness of common strategies for supporting imple-
mentation of a proven QI intervention in CHCs. Figure 1
illustrates how this study fits within a line of inquiry on
improving care quality in CHCs.
The original intervention and implementation strategies
Kaiser Permanente (KP), a large integrated health care
delivery system, developed the “A.L.L. Initiative” (as-
pirin, lovastatin (any statin), lisinopril (any angiotensin-
converting-enzyme (ACE) inhibitor or angiotensin
receptor blocker (ARB)), hereafter called “ALL”). ALL
is a system-level QI intervention designed to increase
the percentage of patients with cardiovascular disease
(CVD)/diabetes mellitus (DM) taking cardioprotective
medications according to national treatment guidelines
[50]. At KP, the ALL intervention uses electronic health
record (EHR) reminders and panel management tools
to help providers identify patients indicated for but not
taking an ALL medication. The ALL implementation
strategies used at KP involve incentivizing providers to
appropriately prescribe the ALL medications (via pay
bonuses related to overall care quality) and directives
identifying it as KP’s standard of care. At KP, ALL led
to an estimated > 60 % reduction in CVD events among
targeted adults [50].
We demonstrated the feasibility of implementing
ALL in CHCs and its effectiveness in this population in
our prior trial [NCT02299791], using ALL to test
cross-setting translational implementation [42, 51]. As
implemented, the intervention improved guideline-
concordant prescribing with relative increases of almost
40 % (previously reported) [42]. We used multiple, con-
current strategies (including staff training, on-site
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facilitation, and performance reports) to support imple-
menting ALL in 11 CHCs. Some CHCs used more in-
tensive support (e.g., multiple staff trainings, repeated
facilitation visits), others less ("just give us the EHR
tools"). Though we showed such implementation to be
feasible in CHCs, we wanted to understand how much
and what type of implementation support would be
needed to efficiently obtain similar success in other
CHCs. Understanding this is relevant to future dissem-
ination of ALL specifically and also provides general
and generalizable knowledge to inform dissemination
of other evidence-based interventions in CHCs. This
purpose, and the fact that implementation strategies are
largely understudied in CHCs, [8, 52–55] underlie the
SPREAD-NET trial.
SPREAD-NET seeks to identify the specific strategies
associated with successfully implementing and sustain-
ing ALL in CHCs and the clinic characteristics associ-
ated with implementation success with different levels/
types of support. To that end, its aims are as follows:
Aim 1: Compare the effectiveness of three
implementation strategies at supporting CHCs’
implementation of the ALL intervention, through a
cluster-randomized trial.
H1: Clinics randomized to receive more
implementation support will be more likely than those
randomized to receive less support (high>medium>low)
to significantly improve the percent of their patients
with (i) guideline-appropriate prescriptions for ACE/
ARBs and statins and (ii) last blood pressure (BP) and
low-density lipoprotein (LDL) under control. H1a.
A minimum amount of support can be identified
for effective, sustainable implementation of the
intervention. H1b. The minimum support needed
will differ between clinics with different characteristics.
Aim 2: Assess intervention sustainability at 12, 24,
and 36 months post-implementation.
H2: Clinics receiving more implementation
support will be more likely to maintain changes.
Aim 3: Identify clinic characteristics associated
with the strategies’ effectiveness





This cluster-randomized trial will compare how three in-
creasingly hands-on strategies support implementation
of ALL in “real world” CHCs. We use a concurrent
mixed methods approach [56] to identify how and why
outcomes are achieved across CHCs, i.e., identifying suc-
cessful support strategies, users’ perceptions of the strat-
egies, and clinic factors that affect success. This work
includes collaborators from the Kaiser Permanente NW
Center for Health Research, OCHIN Inc., Oregon Health
& Science University, Kaiser Permanente Mid-Atlantic
States, Michigan State University, and the participating
CHCs. Approval was obtained from the Kaiser Perma-
nente NW Institutional Review Board.
Study setting
Twenty-nine CHCs, managed by 12 healthcare organi-
zations, are participating. These CHCs share a single
instance of the EpicCare© EHR through membership
in OCHIN, Inc., a non-profit health information tech-
nology organization [57–59]. OCHIN is a national col-
laborative providing health information technology to
CHCs, with >400 member primary care clinics in 19
states. OCHIN members share a single, fully integrated,
centrally hosted Epic© EHR wherein patients have an un-
duplicated, network-wide medical record [60, 61]. OCHIN
also develops EHR-based decision support and panel man-
agement tools, directed by a member-led advisory group,
the Clinical Operations Review Committee (CORC).
Updating the ALL intervention
We adapted the ALL intervention from how it was pre-
sented in our earlier translational study, to align it with
Fig. 1 The SPREAD-NET study in the context of a larger line of research on improving cardiovascular outcomes in socioeconomically vulnerable
patients with diabetes
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updated national guidelines [62–68] and with concurrent
QI activities at OCHIN. To that end, ALL-related com-
ponents were added to a QI “bundle” that OCHIN’s
CORC built for their shared EHR. Designed to address
multiple aspects of DM/CVD care, this set of clinical de-
cision support (CDS) tools is called the CVD risk man-
agement bundle (hereafter, the CVD bundle) and
includes the following:
– “Best practice alerts” (BPAs) that activate in the
EHR when a patient is indicated for an ACE/ARB
and/or a statin, per current guidelines, but has no
prescription for the medication(s). Per these
guidelines, the BPAs also note if patients are
prescribed the recommended statin dosage.
Figure 2 shows a BPA saying the patient is on
statin but is clinically indicated for a higher
intensity dose.
– BPAs that promote accurate charting. For example,
if a patient has high blood pressure but hypertension
is not on their EHR problem list, an alert
suggests adding it. If the patient had a relevant
prescription that had not been renewed in
over a year, an alert recommends updating the
prescription or the chart. These “charting alerts”
serve a dual purpose because the algorithms
underlying the bundle are premised on charting
accuracy. Figure 3 shows a BPA which notes that
the patient’s statin prescription may be out of date.
– Roster/panel management tools that enable
sorting complex patient population data. For
example, they can be used to create lists for
“scrubbing” incoming patients (reviewing the
chart before patient visits to alert the team to
needed care) [69] or for targeted outreach or to
create performance feedback reports, as well as
longitudinal data useful for QI reporting.
Figure 4 shows the roster/panel management tool;
Fig. 5 shows what the roster tool’s list for
“scrubbing” incoming patients.
– “Health maintenance alerts” that activate when
the chart is opened for a patient who is overdue
for DM-related procedures (e.g., foot exams,
HgbA1c screening).
Timeline overview
In May 2014–July 2015, we updated the ALL interven-
tion to represent current guidelines, helped OCHIN’s
CORC to embed the ALL components in the CVD Bun-
dle, developed and fine-tuned the implementation sup-
port strategies, randomized the participating CHCs to
different study arms (each arm receiving a different level
of implementation support), and conducted baseline sur-
veys. In May 2015, the CVD Bundle went live at all
OCHIN clinics. In July 2015, the study CHCs began re-
ceiving the implementation support to which they were
randomized. Follow-up will last 3 years.
Implementation support strategies
The standard practice when OCHIN implements QI
bundles is to activate the associated EHR tools, make
brief instructions for their use and explanations of their
logic available on the OCHIN member website, and e-
mail members to alert them that new tools are in place.
In this case, two 90-minute webinars were also offered
to orient CHCs to the “bundle.”
This study utilizes three main strategies to further fa-
cilitate uptake of the ALL intervention, as embedded in
the CVD Bundle. The strategies are described in detail
in Table 1. In brief, they are the following:
1) CVD Bundle implementation toolkit (all arms).
The toolkit [70] was designed to contain
information that a clinic could use to implement
the CVD bundle. It emphasizes aspects of the
bundle related to cardioprotective prescribing
(the content of the original ALL intervention),
with instructions on generating feedback data and
on how to understand and respond to the bundle’s
automated alerts [34, 71–75]. It also includes
suggestions for how clinics can encourage uptake
of the CVD bundle. Key topics include orienting
clinic staff to the CVD bundle’s medication
guidelines, testimonials from other clinics that
Fig. 2 Alert noting that the patient’s statin dose is too low
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implemented similar guidelines, how to use the
CVD bundle (alerts, roster tools, etc.) including
pre-recorded webinars, tips on how to implement
change, patient education materials (in English and
Spanish), staff education materials, and slide decks
to be used when training clinic staff.
2) In-person training, quarterly follow-up webinars
(arms 2–3). The 2-day in-person training was
held in Portland, Oregon; participants’ travel was
paid for using study funds. In brief, trainees were
taught how to use each aspect of the CVD bundle
and the toolkit and how to teach their clinic
colleagues about both. The first training day
covered why the CVD bundle components were
built, the evidence for their content, and a
hands-on demonstration of the EHR tools. The
second day included a panel session with providers
and staff from CHCs that implemented ALL in our
prior trial and in-depth hands-on training on
change management techniques (e.g., using the Plan-
Do-Study-Act cycle for testing and refining changes
and developing sample clinic workflows).
3) On-site practice facilitation (arm 3). A trained
practice facilitator will go to the study sites and
assist as needed with addressing any identified
barriers to implementing the CVD bundle.
To further facilitate uptake of the ALL intervention,
participating clinics were asked to identify a study
“point person” and a “clinician champion.” We recom-
mended selecting staff members to be point people if
they were interested in diabetes care/cardiovascular
disease prevention, considered credible/influential by
other staff, passionate about care quality, and involved
with clinic QI and/or change management activities. As
seen in Table 2, clinics selected staff with varied back-
grounds (technical, administrative, and clinical) to fill
the point person role. Clinic champions will support
the point person by serving as a resource for other pro-
viders wishing to understand the intervention and as a
role model for other providers considering using the
tools.
Study arms
The 29 study CHCs were randomized to one of three
arms, each arm receiving a different level of implemen-
tation support (Table 1). Randomization was by health-
care organization, to avoid cross-clinic contamination
within organizations, and weighted on number of dia-
betic patients, number of clinics, and urban/rural status.
Study data, variables, and measurement
Variable selection
Variable selection was guided by Reach, Effectiveness,
Adoption, Implementation, Maintenance (RE-AIM), a
widely accepted framework for evaluating implementa-
tion of interventions [1, 76–78]. The primary independ-
ent variable is study arm. Dependent variables will
represent measures of how effectively each strategy sup-
ports sustainable implementation of ALL. Our primary
dependent variables will be change in rates of guideline-
concordant prescribing of cardioprotective medication
(ACE/ARBs, statins) among patients with diabetes. We
Fig. 3 Alert noting that the patient’s statin order is outdated
Fig. 4 The roster/panel management tool
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will also assess process outcomes. Table 3 lists details
measures and data sources.
Baseline survey
We hope to describe characteristics of the clinics that
have more or less implementation success at each level
of support, to explore how such characteristics impact
the ability to implement the tools in the CVD risk man-
agement bundle and how these factors impact the effect-
iveness of each implementation strategy [78–80]. To
that end, we created two surveys to gather baseline prac-
tice characteristics: (i) the all-staff survey, designed to
assess clinics’ readiness to change, and (ii) the clinic in-
formation form survey (CIF), designed to collect factual
information about each clinic. While we will not have
adequate power to conduct statistical assessments of as-
sociation between survey findings and study outcomes,
we intend to use these data to inform subsequent quali-
tative data collection and analysis and to generate hy-
potheses for future intervention analyses.
Survey item selection was informed by the literature on
practices’ “readiness to change” [81–93] and input from
CHC staff from our prior trial; surveys were piloted prior
to finalizing. The final all-staff survey incorporates the
adaptive reserve scale [94, 95] and the organizational
readiness to change assessment instrument’s [96] context
assessment subscale, as well as questions about per-
ceived capacity to implement change, perceived QI
needs, and staff demographics. The CIF covers ques-
tions about ownership, staffing, revenue, billing, and in-
surance characteristics and prior experiences with
change. In addition, data from OCHIN records and the
EHR will provide baseline information on EHR go-live
dates, meaningful use attestation, and characteristics of
the patient population. Study point people distributed
and collected the all-staff surveys to all clinic staff (to
ensure confidentiality staff were asked to seal their
completed survey in a study-provided manila envelope
and place a “confidential” sticker across the seal before
returning to the point person); respondents received a
$5 gift card after returning the completed survey. Point
people also facilitated completion of the CIF by a clinic
manager or QI coordinator.
Quantitative data
Our primary outcome of interest is clinic-level rates of
guideline-concordant ACE/ARB and statin prescribing.
We note that although the clinical success of ALL is
dependent on patients taking recommended and pre-
scribed medications, the first step—and SPREAD-NET’s
primary outcome measure—is prescription of these
medications. Quantitative data will capture medication
Fig. 5 The roster tool’s list for “scrubbing” incoming patients
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Table 1 SPREAD-NET implementation components






CVD risk management bundle
implementation toolkit
• Overview of OCHIN’s DM/CVD QI bundle X X X
• Staff training/patient education materials
• Documents to support ALL implementation: underlying evidence
• How to use bundle tools in workflows
• Additional tools: posters, patient handouts, after-visit summary text
• Webinar on how to use the toolkit
• How to train your clinic staff to use the bundle
• How to implement practice changes, e.g., Plan-Do-Study-Act (PDSA)
cycles [110–118]
• Annual webinars with updates
• Relevant references and links
In-person training, quarterly follow-up
webinars
• 2-day training in Portland, Oregon: how to use the bundle, and how to train
others to use it
X X
• Hands-on training in how to use bundle tools (e.g. panel management)
• Focus on building skills around change management techniques (e.g.,
PDSA cycles)
• Quarterly webinars; topics chosen by clinics to enhance implementation
skills
On-site practice facilitation • Up to 5 visits per clinic, including: X
Staff presentations
Coaching on presenting the tools to clinic staff, and using the tools in clinic
workflows
Tailored problem-solving support to address barriers
Clinical questions fielded by practice facilitator
• Ongoing telephone/e-mail support as needed
Table 2 Point people and clinic champions
Healthcare organization Study arm # of clinics # of adult patients w/DM # of point persons/clinic champions; role(s)
1 1 1 224 1: nurse care manager
2 1 1 547 1: physician’s assistant
3 1 2 1520 2: physician/medical director (both)
4 1 5 1781 2: clinical site specialist; patient population specialist
Arm total 9 4072 6 total
5 2 2 565 1: nurse practitioner
6 2 2 937 1: physician/medical director
7 2 2 246 1: physician/medical director
8 2 5 3320 3: epic EHR site specialists
Arm total 11 5060 6 total
9 3 1 556 1: clinical data analyst
10 3 2 493 1: nurse
11 3 2 871 2: pharmacy director; pharmacist
12 3 4 1740 4: director of performance improvement/population health;
mental health/substance abuse counselor/social worker;
patient advocate; office manager
Arm total 9 3660 8 total
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orders/prescribing rates, changes in clinical outcomes
(blood pressure and lipids), and decision support tool
usage/responses. It will be extracted monthly from
OCHIN’s EHR database using structured queries. Add-
itional patient, provider, and encounter-level data will be
extracted as necessary to control for confounding in our
models. OCHIN’s EHR data is regularly cleaned and vali-
dated, ensuring data quality.
Qualitative data
We will use observation, interviews, and document re-
view to explore the implementation process (e.g., how
the toolkit was used/adapted in CHC workflows), how
each support strategy affected implementation and sus-
tainability, and facilitators and barriers to intervention
uptake. Site visits will be conducted at clinics in all three
study arms, purposively selected to maximize variation
and optimize learning. Details are in Table 4.
Analyses
Quantitative
For aim 1, we will use an interrupted time-series design
and segmented regression to assess differences in the
implemented intervention’s impact on patient health
(effectiveness) and guideline-based prescribing (reach)
[97–99]. Time in monthly intervals will be the unit of
observation. The segmented regression model will esti-
mate prescribing rates in the 18 months pre-
implementation and how these change in the first year
post-implementation. We will measure both the
immediate effect of the intervention and estimate the
effect across time. We will test whether the pre-post
intervention change in trends in the rates over time dif-
fers across arms, as well as the immediate effect of the
intervention. Aim 2 analyses will use the same approach,
adding time points through 36 months post-intervention
(maintenance). The time period variable will have three
levels (pre-intervention, 12 months post-intervention, and
13–36 months post-intervention).
We will also conduct secondary analyses in which we
will define thresholds of intervention impact. We will
then assess the minimal amount of implementation sup-
port needed to achieve threshold results, using logistic
regression models, with study arm predicting a binary
outcome for threshold achieved by 12 months. These
analyses will include an additional control group, using
data from > 300 OCHIN CHCs not formally participat-
ing in the study, so that study arm has four levels of im-
plementation support: none, low, medium, high. The
“none” group will be the reference category, to assess if
each of three implementation support approaches
achieves the threshold target relative to no intervention.
Qualitative
Qualitative data collection and analysis will be concur-
rent and iterative, permitting us to identify salient con-
structs and knowledge gaps while implementation is
ongoing, incorporate this knowledge into subsequent
data collection, and guide adaptation of the support
strategies [100–109]. The aim will be to understand
Table 3 Study variable measurement
RE-AIM components Measure Data source
Reach: rate of guideline-appropriate prescribing of
ACE/ARBs, statins
[primary dependent variables]
(a) % clinic’s “indicated” patients with an active prescription
(Rx issued in last year) for each indicated medication group
(b) % of patients indicated for statins, on the correct dosage
Monthly EHR data
Effectiveness: proportion of patient BP, LDL
“under control”
(targeted by statins, ACE/ARBs, respectively)
[secondary outcome]
% clinic’s “indicated” patients with:(a) last systolic BP <135,
last diastolic BP <80(b) last LDL <100





(a) % indicated patient encounters where
(i) appropriate prescription given
(ii) statin dosage corrected
(b) rates of use of the roster tools
(c) rates of responses to “charting alerts:” how often
the recommended change is made in the chart
(d) rates of responses to health maintenance alerts:
data entered/recommended care provided
(e) % staff attending relevant trainings(f) perceived
value of patient/staff education materials
Monthly EHR data; qualitative data
Implementation: Compliance with,
fidelity / adaptation to toolkit elements
across and within sites
How toolkit elements are used: e.g., use of staff training
materials, patient education materials, patient panel
management rosters, other reminder tools; any
adaptations made to these materials
Qualitative data
Maintenance: uptake of toolkit elements; primary,
secondary outcome effects, over time
All measures at 1, 2, 3 years post-implementation EHR, qualitative data
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implementation from the participants’ perspective, in-
cluding barriers and facilitators, the extent to which
toolkit elements are used or adapted (adoption), and the
impact of each support strategy on implementation suc-
cess (implementation). Attention will be paid to factors
leading to a given practice excelling or struggling in re-
sponse to the offered implementation support.
Costs
One key aspect of this study is the cost comparison for
each strategy—an important consideration when repli-
cating the intervention at future CHCs. We will identify
the costs associated with each support strategy (such as
programming, training clinic staff, other staff time
needs, etc.). We will also estimate the incremental cost
per additional unit of effect (e.g., cost per person gain-
ing appropriate cardioprotective medication, cost per
100 additional patients receiving guideline-appropriate
medication).
Trial status
At the time of manuscript submission, the SPREAD-
NET study is beginning year 2 of 5.
Discussion
While substantial research has identified interventions
that improve care quality, little is known about how to
implement such interventions most effectively and effi-
ciently in diverse care settings. Very little research has
directly compared the effectiveness of different imple-
mentation strategies, especially in “real-world” clinics
serving vulnerable populations; in fact, little prior re-
search differentiated between the intervention being
tested, and the methods used to implement it. The
SPREAD-NET trial is designed to assess the level and
type of support needed to successfully implement an
EHR-based QI intervention in diverse CHCs and thus
to fill these knowledge gaps about effective implemen-
tation in general and in the safety net setting in
particular.
SPREAD-NET is poised to contribute important evi-
dence about effective strategies for improving health
care delivery by comparing approaches to helping CHCs
implement an evidence-based “bundle” of decision sup-
port tools. As shown in Fig. 1, it fits within a larger line
of research. First, the effectiveness of statins and ACE/
ARBs at preventing CVD events in people with diabetes
was demonstrated. Then, KP showed ALL’s effectiveness
Table 4 Qualitative data collection methods
Method Type Who/what When How often / many Why

















As possible during 2-day
site visits (12)
Personal experience with
“bundle” tools; barriers and
facilitators to use






per clinic during 2-day
site visits (12)
Perception of implementation/




Phone interview CHC providers and
staff at clinics not
visited in person
Study years 3–4 Minimum 2 interviews
per clinic
Perception of implementation/

















Over course of 2-day
site visits (12)
How intervention tools used







CHC staff; clinic policies; etc.)
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at implementing practice changes related to identifying
patients indicated for these medications. Our first trial
showed that ALL could be adapted for and imple-
mented in CHCs, using concurrent, diverse implemen-
tation strategies. SPREAD-NET is designed to evaluate
how much and what kind of implementation strategies
are needed in CHCs; thus, it addresses the “final mile”
involved in turning new scientific knowledge into prac-
tice. While SPREAD-NET uses a diabetes-focused
intervention as our test case, findings are expected to
apply to diverse interventions involving practice change
implementation and implementation of evidence-based
care guidelines.
Given that the field of D&I science is nascent,
SPREAD-NET may serve as a model for future trials in-
terested in identifying methods for encouraging uptake
of EHR-based decision support, by clearly differentiating
between the intervention and the methods used to im-
plement it. This trial’s mixed methods design is import-
ant, as it will allow us to understand not just how often
clinics acted on the targeted practice change but also
why certain approaches did or did not work well in
clinics with different characteristics. This protocol paper
thus demonstrates methods for using mixed methods in
implementation research.
In conclusion, the SPREAD-NET trial described here
is an empirical example of the research that is needed
to allow us to accelerate implementation timelines and
reduce disparities in health care and health outcomes,
especially in CHCs. It has the potential to contribute
much-needed knowledge to the field of implementation
science and to serve as a model for future research on
how to implement effective interventions in diverse
care settings.
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